Nestlé Health Science
Nestlé Pays $2bn To Secure Aimmune's Allergy Treatment
Nestlé plans to pay $2 billion (€1.7 billion) to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss compa...
Nestlé Health Science To Acquire IM HealthScience
Nestlé Health Science has agreed to acquire the business of IM HealthScience (IMH) which includes the brands IBgard, FDgard, Fiber Choice and REMfre...

Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today Enjoy unlimited digital access for 30 days

Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today Enjoy unlimited digital access for 30 days
Copyright © 2023. All rights reserved. Developed by Square1 and powered by PublisherPlus.com